SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-24-004389
Filing Date
2024-03-12
Accepted
2024-03-12 13:45:40
Documents
1
Period of Report
2024-03-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-65141.html 4  
1 PRIMARY DOCUMENT marketforms-65141.xml 4 5655
  Complete submission text file 0001214659-24-004389.txt   7148
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Schobel Alexander Mark (Reporting) CIK: 0001406836 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 24741391